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The aim of this study was to evaluate the activity of the ethanolic extract of geopropolis (EEGP) from Melipona scutellaris and
its fractions on the modulation of neutrophil migration in the inflammatory process, and the participation of nitric oxide (NO)
pathway, as well as to check the chemical profile of the bioactive fraction. EEGP and its aqueous fraction decreased neutrophil
migration in the peritoneal cavity and also the interaction of leukocytes (rolling and adhesion) with endothelial cells. The levels
of chemokines CXCL1/KC and CXCL2/MIP-2 were not altered after treatment with EEGP and the aqueous fraction. It was found
that the injection of NO pathway antagonists abolished the EEGP and the aqueous fraction inhibitory activity on the neutrophil
migration. The expression of intercellular adhesion molecule type 1 (ICAM-1) was reduced, and nitrite levels increased after
treatment with EEGP and aqueous fraction. In the carrageenan-induced paw edemamodel, EEGP and the aqueous fraction showed
antiedema activity. No pattern of flavonoid and phenolic acid commonly found in propolis samples of Apis mellifera could be
detected in the aqueous fraction samples. These data indicate that the aqueous fraction found has promising bioactive substances
with anti-inflammatory activity.
1. Introduction
Neutrophils have key involvement in defending the body
during the inflammatory process. The process of neutrophil
rolling and adhesion to endothelial cells, followed by its
transmigration to the extravascular space, occurs due to the
release of lipidicmediators, cytokines and chemokines, which
activate selectins, integrins, and immunoglobulin [1, 2].
On the other hand, although recruitment of neutrophils
is a protective response of the organism, the occurrence of
an intense response can produce undesirable effects, that can
lead to a progressive tissue damage in the inflamed site. This
phenomenon occurs in different inflammatory diseases, such
as rheumatoid arthritis and periodontal disease [3, 4].
The development of new anti-inflammatory drugs that
interfere with the neutrophils trafficking on the inflammatory
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focus has attracted great interest among researchers, and the
sought strategies are by inhibiting of rolling, transmigration,
and adhesion of neutrophils on the inflammatory focus,
either by blocking of molecules involved in this process
or stimulating mediators such as nitric oxide (NO), which
inhibits this event [5–7].
Natural products have been researched for decades as a
promising source in the discovery of new drugs, and Apis
mellifera bee propolis has been reported in the literature as
possessing various biological activities [8–10]. In addition,
Apis mellifera propolis has been demonstrated as a source
of natural resource for the discovery of new bioactive com-
pounds, such as artepelim C [11], apigenin and tt-farnesol
[12], and CAPE [9], among others.
Geopropolis, a mixture of resin, wax, and soil, is an
uncommon propolis collected by native stingless bees of
the Meliponini tribe and widely found in tropical and
subtropical areas worldwide [13, 14]. Among the geopropolis,
the one from the Melipona scutellaris bee species has been
target of interest of our research group. Studies with geo-
propolis observed significant antimicrobial activity against
Staphylococcus aureus [15] and antinociceptive activity [16],
suggesting that further studies should be conducted in order
to identify other biological activities as well as the elucidation
of its whole chemical profile, aimed at identifying promising
chemicals with pharmacological potential.
Thus, the aim of this study was to evaluate the activity of
the ethanolic extract of geopropolis (EEGP) from Melipona
scutellaris and its fractions on the modulation of neutrophil
migration in the inflammatory process, and the participation
of NO pathway, as well as to check the chemical profile of the
bioactive fraction.
2. Material and Methods
2.1. Geopropolis Samples and Fractionation. The geopropolis
samples were collected between June and July 2010 in the sea-
side region, municipality of Entre Rios (11∘57󸀠 S, 38∘05󸀠W),
state of Bahia, Northeast of Brazil. Geopropolis (100 g) was
extracted with absolute ethanol (w/v) of proportion (1/7), at
70∘C, for 30min, and then filtered to obtain the EEGP. The
EEGP was further fractioned using a liquid-liquid extrac-
tion technique with hexane, chloroform, and ethyl acetate
solvents. At the end of three partitions, it was obtained a
residue called aqueous fraction [16]. The fractions obtained
were monitored by thin layer chromatography (TLC) using
the anisaldehyde reagent, followed by incubation at 100∘C for
5min. Fluorescent substances were visualized underUV light
at the wavelengths of 254 and 366 nm [17]. The EEGP and
its hexanic, chloroform, ethyl acetate, and aqueous fractions
were concentrated in a rotaevaporator at 40∘C to obtain yields
of 4.33% (w/w), 1.98% (w/w), 0.23% (w/w), 0.87% (w/w),
and 1.25% (w/w), respectively. The extract and fractions
were dissolved in DMSO 1% (dissolved in PBS at 1mM) for
subcutaneous (s.c.) administration.
2.2. Animals. Male SPF (specific-pathogen free) BALB/c
mice weighing 20–25 g were housed in temperature of
22–25∘C, with a light cycle of 12 h light/12 h dark, humidity
of 40–60%, and with access to water and food ad libitum.
The procedures described were reviewed and approved by the
local animal Ethics committee (CEUA Unicamp process no.
2037-1).
2.3. Drugs and Reagents. Carrageenan, aminoguanidine
(AG), [1H-(1,2,4)oxadiazolo (4,3-a) quinoxalin-1-one]
(ODQ), and dimethylsulphoxide (DMSO) were obtained
from Sigma Chemical Co. (St. Louis, MO, USA) and organic
solvents fromMerck.
2.4. Biological Protocols
2.4.1. Evaluation of the Activity of EEGP and Its Fraction
on Neutrophil Migration in the Peritoneal Cavity Induced by
Carrageenan. The mice were pretreated with EEGP, hexane,
chloroform, ethyl acetate, or aqueous fractions (1, 3, 10,
or 30mg/kg, s.c.). The negative control group received the
vehicle. After 30min of treatment, it was applied carrageenan
IP at a dose of 500𝜇g/cavity. After 4 h, the animals were killed
and the peritoneal cavity washed with 3mL of PBS/EDTA
(1mM). For total cell counting, it was utilized the Neubauer
chamber, and for differential counting, it was performed
by preparing smears in a cytocentrifuge (citospin; Shandon
Lipshaw Inc., Pittsburgh, PA, USA), which were stained with
fast Panotic kit, and for differentiated cells (100 cells total), an
optical microscope (1000× increase) was utilized. The results
were expressed as number of neutrophils per cavity [18].
2.4.2. Evaluation of the Activity of EEGP and Its Bioac-
tive Fraction on the Rolling and Adhesion of Leukocytes
in the Mesenteric Microcirculation by Intravital Microscopy.
The mice were pretreated with EEGP or aqueous fraction
(10mg/kg, s.c.) 30min before the IP injection of carrageenan
500𝜇g/cavity. The negative control group received the vehi-
cle. After 2 and 4 h since the inflammatory stimulus, the
rolling and adhesion of leukocytes were rated as previously
described [19, 20]. The animals were anesthetized, and the
mesenteric tissue was exposed to in situ assessment by
intravitalmicroscopy.The animalswere placed on a platewith
a thermostat at 37∘C, where the mesenteric tissue was kept
warm and moist with Ringer Locke solution (pH from 7.2 to
7.4) containing 1% of gelatin.The postcapillary venules, which
had a diameter of 10–18 𝜇m, were chosen, and the interaction
of leukocytes with the luminal surface of the endothelium
venule was assessed, where we counted the number of rolling
leukocytes for 10min. Leukocytes were considered adherent
to the endothelium if they remained stationary for>30 s. Cells
were counted, and the image was recorded using five different
fields for each animal to avoid variability due to sampling.
Calculations were made for each animal.
2.4.3. Evaluation of Chemokines Levels after Treatment with
EEGP and Bioactive Fraction. Themice were pretreated with
EEGP or aqueous fraction (10mg/kg, s.c.). The negative
control group received the vehicle. After 30min of treatment,
it was applied carrageenan IP at a dose of 500𝜇g/cavity.
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Figure 1: Inhibitory effect of the ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on neutrophils migration into the
peritoneal cavity induced by carrageenan. Neutrophil migration was determined 4 h after the injection of carrageenan 500𝜇g/cavity. Mice
previously treated with vehicle (saline and carrageenan), EEGP (a), hexane fraction (HF-(b)), chloroform (CF-(c)), ethyl acetate (EAF-(d)),
or aqueous (AF-(e)). The data are expressed as mean ± SEM, 𝑛 = 6. Symbols indicate statistical difference (𝑃 < 0.05, Tukey test). #Compared
to the saline group; ∗compared to the carrageenan group.


















































Figure 2: Inhibitory effect of the ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on rolling (a) and adhesion (b) of
leukocytes assessed by intravital microscopy in mesenteric tissue of mice, 2 and 4 h after IP injection of carrageenan 500𝜇g/cavity. Mice
were pretreated with vehicle (saline and carrageenan), EEGP, or aqueous fraction (10mg/kg). The data are expressed as mean ± SEM, 𝑛 = 5.

































Figure 3: Effect of the ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on the levels of CXCL1/KC (a) and CXCL2/MIP-2
(b) 3 h after the injection of 500 𝜇g/cavity of carrageenan in the peritoneal cavity. Mice were pretreated with vehicle (saline and carrageenan),
EEGP, or aqueous fraction (10mg/kg, s.c.). The data are expressed as mean ± SEM, 𝑛 = 5. Symbols indicate statistical difference (𝑃 < 0.05,
Tukey test). #Compared to the saline group.
After 3 h, the animals were killed and the peritoneal cavity
washedwith 3mLof PBS/EDTA (1mM). Levels ofCXCL1/KC
and CXCL2/MIP-2 were determined by ELISA using proto-
cols supplied by the manufacturers (R&D Systems, Inc). The
results are expressed as picograms.
2.4.4. Effect of Inhibitors of NO Pathway on the EEGP
Inhibitory Effect and Bioactive Fraction on Neutrophil Migra-
tion in the Peritoneal Cavity Induced by Carrageenan. The
animals were pretreated with a selective inhibitor of iNOS
(aminoguanidine 50mg/kg, s.c.) or a selective inhibitor of
soluble guanylate cyclase (ODQ 5𝜇mol/kg, IP) 30min before
EEGP or aqueous fraction (10mg/kg, s.c.) administration.
The negative control group received the vehicle. After 30min
of treatment, it was applied carrageenan at a dose of
500𝜇g/cavity and neutrophil migration was determined as
described in the Section 2.4.1 [18, 21].
2.4.5. Evaluation of ICAM-1 Expression by Western Blotting
after Treatment with EEGP and Bioactive Fraction. Themice
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Figure 4: Inhibitory effect of the ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on neutrophils migration into the
peritoneal cavity induced by carrageenan. Neutrophil migration was determined 4 h after the injection of carrageenan 500𝜇g/cavity. Mice
were pretreated with aminoguanidine (AG—50mg/kg, (a)) and ODQ (5𝜇mol/kg, (b)) antagonists. After 30min, the animals were pretreated
with vehicle (saline and carrageenan), EEGP, or aqueous fraction (10mg/kg).The data are expressed as mean ± SEM, 𝑛 = 6. Symbols indicate
statistical difference (𝑃 < 0.05, Tukey test). #Compared to the saline group; ∗compared to the carrageenan group; ∗∗compared to the groups
that received only EEGP and the aqueous fraction.
were pretreated with EEGP or aqueous fraction (10mg/kg,
s.c.). The negative control group received the vehicle. After
30min of treatment, it was applied carrageenan IP at a
dose of 500𝜇g/cavity. After 4 h, the animals were killed,
then the mesenteric tissue was dissected, and the proteins
were isolated. Tissues were lysed in 400mL of buffer (1%





aprotinin, 1mg/mL leupeptin, and 1mg/mLPMSF) and cen-
trifuged at 4∘C for 20min at 12.300/g. Equal amounts of
protein (50𝜇g) were separated by 10% SDS-PAGE and trans-
ferred to a nitrocellulose membrane (Bio-Rad). The standard
molecular weight (Bio-Rad) was run in parallel to estimate
the molecular weight. Membranes were blocked, overnight
at 4∘C, in TBS-T (20mMTris-HCl (pH 7.5), 500mMNaCl,
and 0.1% Tween 20) plus 5% of nonfat skimmedmilk powder.
After the blocking, themembranes were incubated, overnight
at 4∘C, with rabbit anti-ICAM-1 (1 : 200) or 𝛼-tubulin (Santa
Cruz Biotechnology) and utilized as an internal control
(1 : 1000) diluted in TBS-T containing 5% of nonfat skimmilk
powder. The membranes were then incubated with rabbit
anti-IgG conjugated to peroxidase (1/2000) diluted in TBS-T
containing 5% of nonfat milk powder at room temperature
for 30min. Finally, the bands recognized by the specific
antibody were visualized using a chemiluminescence-based
ECL system (Amersham Biosciences) and exposed to an X-
ray film for 30min (Eastman Kodak). A computer imaging
system (Gel-Pro Analyzer) was utilized to measure the
intensity of the OD of the bands.
2.4.6. Evaluation of Nitrite Levels after Treatment with EEGP
and Bioactive Fraction. Themice were pretreated with EEGP
or aqueous fraction (10mg/kg, s.c.). The negative control
group received the vehicle. After 30min of treatment, it was
applied carrageenan IP at a dose of 500 𝜇g/cavity. After 4 h,
the animals were killed and the peritoneal cavity washed
with 3mL of PBS/EDTA (1mM). The production of NO was
determined in the peritoneal lavage using the Griess method
[22] by measuring the nitrite concentration at 540 nm.
2.4.7. Evaluation of the Activity of EEGP and Its Bioactive
Fraction on Carrageenan-Induced Paw Edema. The mice
were pretreated with EEGP or aqueous fraction (1, 3, 10,
or 30mg/kg, IP). The negative control group received the
vehicle. After 30min of treatment, the animals were subjected
to an intraplantar injection of 50 𝜇L carrageenan (1mg/paw)
in the left hind leg. The animal’s paw volume was measured
before (time 0) and after injection of carrageenan (1, 2, 3,
4, and 5 h) utilizing a plethysmometer (Ugo Basile, Model
7150, Italy).The results were expressed as the threshold of the
inflamed paw Δ (mL), which was calculated by subtracting
the values obtained before (time 0) and after the injection of
carrageenan [23].
2.5. Chemical Analysis of the Bioactive Fraction
2.5.1. High-Performance Liquid Chromatography Reverse
Phase. Ten microliters of sample (aqueous fraction) were
injected into a liquid chromatograph coupled to a photodiode
array detector at 260 nm, and the sample were eluted through
a C18 reverse phase column (250× 4.6mm), with particle size
of 5 𝜇m. The mobile phase was water/acetic acid (98/2) (sol-
vent A) and water/acetonitrile/acetic acid (68/30/2) (solvent
B) with constant rate of 1mL/min. The gradient started with
0 to 30% of solvent B in 20min, 30 to 50% of B in 10min,





































Figure 5: Effect of the ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on the expression of ICAM-1 (a) and nitrite
levels (b) 4 h after the injection of 500 𝜇g/cavity of carrageenan (Cg) in the peritoneal cavity. Mice were pretreated with vehicle (saline and
carrageenan), EEGP, or aqueous fraction (10mg/kg, s.c.).The data are expressed as mean ± SEM, 𝑛 = 5. Symbols indicate statistical difference
(𝑃 < 0.05, Tukey test). #Compared to the saline group; ∗compared to the carrageenan group.
Table 1: EEGP effect on carrageenan-induced paw edema on mice.
Treatment (mg/kg) Time (h) after injection of carrageenan
1 2 3 4 5
Carrageenan 0.06 ± 0.01 0.08 ± 0.01 0.13 ± 0.02 0.16 ± 0.01 0.15 ± 0.01
EEGP 1mg/kg 0.04 ± 0.01 0.05 ± 0.02 0.06 ± 0.02∗ 0.11 ± 0.02 0.12 ± 0.02
EEGP 3mg/kg 0.05 ± 0.01 0.06 ± 0.01 0.05 ± 0.01∗ 0.12 ± 0.01 0.15 ± 0.01
EEGP 10mg/kg 0.05 ± 0.01 0.05 ± 0.01 0.05 ± 0.02∗ 0.12 ± 0.01 0.13 ± 0.01
EEGP 30mg/kg 0.05 ± 0.01 0.05 ± 0.01 0.05 ± 0.01∗ 0.06 ± 0.01∗ 0.05 ± 0.02∗
The data are expressed as mean ± SEM, n = 6. Symbols indicate statistical difference (P < 0.05, Tukey test). ∗Compared to the carrageenan group.
50 to 70% of B in 20min, 70 to 100% of B in 5min, 100%
of B in 20min, and 100 to 0% of B in 10min [24]. We
utilized authentic standards of flavonoids and phenolic acids
to compare the retention time of substances in the aqueous
fraction sample.
2.6. Statistical Analysis. Data were expressed as mean ± stan-
dard error of the mean (SEM), and statistical comparisons
between groups were made utilizing analysis of variance
(ANOVA) followed by Tukey test. Significance was accepted
when 𝑃 < 0.05.
3. Results
3.1. EEGP and Aqueous Fraction Inhibit Neutrophil Migration
in the Peritoneal Cavity. We evaluated the activity of EEGP
and its aqueous fraction on neutrophil migration in the
peritoneal cavity induced by carrageenan. Regarding the
results, it was found that administration of EEGP decreased
the influx of neutrophils into the peritoneal cavity, compared
to the carrageenan group (𝑃 < 0.05). It was observed
an inhibition of 41, 61, 62, and 50% for doses of 1, 3,
10, and 30mg/kg (Figure 1(a)), respectively. Concerning the
chemical fractions studied, the hexane fraction (Figure 1(b)),
the chloroform fraction (Figure 1(c)), and the ethyl acetate
fraction (Figure 1(d)) showed no significant inhibition of
neutrophil recruitment (𝑃 > 0.05). On the other hand, the
aqueous fraction decreased the number of neutrophils in the
peritoneal cavity after injection of carrageenan (𝑃 < 0.05),
where we observed an inhibition of 66 and 64% for doses of
10 and 30mg/kg, respectively (Figure 1(e)).Thus, the aqueous
fraction was selected as the bioactive fraction of EEGP.
3.2. EEGP and Aqueous Fraction Inhibit the Rolling and
Adhesion of Leukocytes. By checking the activity on the
inhibition of neutrophilmigration in the peritoneal cavity, we
evaluated the activity of EEGP and aqueous fraction on the
rolling and adhesion of leukocytes to endothelial cells. Based
on the results, we found that EEGP and the aqueous fraction,
at a dose of 10mg/kg, decreased leukocyte rolling and
adhesion to endothelial cells, compared to the carrageenan
group (𝑃 < 0.05), with an inhibition of 48 and 58%
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Table 2: Aqueous fraction effect on carrageenan-induced paw edema on mice.
Treatment (mg/kg) Time (h) after injection of carrageenan
1 2 3 4 5
Carrageenan 0.08 ± 0.01 0.10 ± 0.02 0.13 ± 0.01 0.16 ± 0.02 0.15 ± 0.01
Aqueous fraction 1mg/kg 0.10 ± 0.01 0.11 ± 0.01 0.11 ± 0.01 0.14 ± 0.01 0.13 ± 0.01
Aqueous fraction 3mg/kg 0.08 ± 0.01 0.09 ± 0.02 0.09 ± 0.01 0.13 ± 0.01 0.13 ± 0.01
Aqueous fraction 10mg/kg 0.06 ± 0.01 0.08 ± 0.01 0.08 ± 0.02 0.11 ± 0.02 0.11 ± 0.01
Aqueous fraction 30mg/kg 0.06 ± 0.01 0.05 ± 0.02 0.06 ± 0.02∗ 0.08 ± 0.03∗ 0.09 ± 0.02
The data are expressed as mean ± SEM, n = 6. Symbols indicate statistical difference (P < 0.05, Tukey test). ∗Compared to the carrageenan group.
for the rolling (Figure 2(a)) and 75 and 61% for the adhesion
of leukocytes (Figure 2(b)), respectively.
3.3. EEGP and Aqueous Fraction Promote No Changes
Chemokines Levels in Mice Subjected to Injection of Car-
rageenan in the Peritoneal Cavity. In order to elucidate the
mechanism of action by which EEGP and the aqueous
fraction inhibit neutrophil migration, we initially studied
their action on the synthesis and/or release of chemokines.
Thus, we found that EEGP and the aqueous fraction, at
a dose of 10mg/kg, did not alter levels of chemokines
CXCL1/KC (Figure 3(a)) and CXCL2/MIP-2 (Figure 3(b))
in animals subjected to IP injection of carrageenan (𝑃 >
0.05).
3.4. Inhibitors of NOPathwayCause Suppression of the Effect of
EEGP and Aqueous Fraction on Neutrophil Migration Induced
by Carrageenan. After, we evaluated the participation of the
NO pathway. According to the results, we observed that the
application of antagonists of NO pathway (Figures 4(a) and
4(b)) abolished the inhibitory effect of EEGP and aqueous
fraction, at a dose of 10mg/kg, on neutrophil migration
induced by carrageenan (𝑃 < 0.05), thus confirming that
the inhibitory action of recruitment of neutrophils is at least
partly due to the NO pathway.
3.5. EEGP and Aqueous Fraction Decrease the Expression
of ICAM-1 and Increase Nitrite Levels in Mice Subjected to
Injection of Carrageenan in the Peritoneal Cavity. Regarding
the expression of adhesion molecules ICAM-1, we observed
that treatment with EEGP and aqueous fraction, at a dose of
10mg/kg, reduced its expression (𝑃 < 0.05) when compared
to the carrageenan group (Figure 5(a)). Besides, the treatment
with EEGP and aqueous fraction (10mg/kg) increased the
nitrite levels (𝑃 < 0.05) when compared to the carrageenan
group (Figure 5(b)).
3.6. Antiedematogenic Activity of EEGP and Aqueous Fraction
on PawEdema. Weverified the activity of EEGP and aqueous
fraction on carrageenan-induced paw edema. According to
the results, we found that EEGP showed antiedematogenic
activity (Table 1), and we observed an inhibition of 57, 60, 62,
and 62% for doses of 1, 3, 10, and 30mg/kg (3 h) and 66%
(4 and 5 h after injection of carrageenan) for the 30mg/kg
dose.
Furthermore, the aqueous fraction was able to reduce the
edema only for the dose of 30mg/kg, showing an inhibition
of 56% (3 h) and 49 % (4 h) (Table 2).
3.7. High-Performance Liquid Chromatography Reverse Phase.
According to the chromatograms obtained by high-perfor-
mance liquid chromatography reverse phase (HPLC-FR) of
the aqueous fraction (Figure 6), we could verify the existence
of two major compounds that were not compatible with any
of the standards utilized.
4. Discussion
The present study demonstrated that the EEGP and its
aqueous fraction decreased leukocyte interaction (rolling
and adhesion) with endothelial cells as well as neutrophil
migration into the peritoneal cavity of mice subjected to
intraperitoneal injection of carrageenan through suppression
of adhesion molecules ICAM-1, which is an NO pathway-
dependent activity.
The inflammatory process is a set of events arising from
the participation of various mediators that promote vascular
and cellular events [5, 25]. NO plays different physiological
functions in the body. Its production involves the participa-
tion of a family of enzymes known as NO synthases (NOS).
Among them, the inducible NOS (iNOS) is activated during
the inflammatory process [18, 21, 26].
Recent studies have shown that the inhibitory effect of
NO (via iNOS) on migration of neutrophils in the inflam-
matory process is dependent on the activation of enzyme
soluble guanylate cyclase (sGC). The activation of the sGC
leads to an increase in the production of guanosine 3󸀠5󸀠-cyclic
monophosphate (cGMP) and consequent inhibition of the
ICAM-1 adhesion molecules [18, 21].
The present study demonstrated that treatment with
specific antagonists of iNOS or the sGC suppressed the
inhibition of neutrophil migration by EEGP and its aqueous
fraction. These results suggest, therefore, that the inhibitory
effect of EEGP and the aqueous fraction on neutrophils
migration by NO pathway is related to increased levels of NO
(via iNOS activation), which can be observed by the increase
in nitrite levels and consequent activation of the sGC/cGMP
pathway, thus leading to the suppression of ICAM-1 adhesion
molecules.
As edema is one of the key events in the inflammatory
response, we also evaluated the effectiveness of EEGP and
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Figure 6: Chromatograms obtained by HPLC-RP of the aqueous fraction. 1: UV 𝜆 240 nm, RT = 3.71min; 2: UV 𝜆 238 nm, RT = 32.36min.
the aqueous fraction on carrageenan-induced paw edema.
The first phase (0–3 h) of carrageenan-induced paw edema
is associated with increase in the histamine, serotonin,
and kinins chemical mediators, and these are related with
the increase in vascular permeability, besides the increased
production of the IL-1𝛽 and TNF-𝛼 cytokines [27–29]. In
the second phase (3-4 h) there is a production of mediators
derived from the inducible cyclooxygenase enzyme, such as
prostaglandins, and this second phase is sensitive to anti-
inflammatory cyclooxygenase inhibitors [27, 28]. According
to the results presented, EEGP and its aqueous fraction
decreased the carrageenan-induced paw edema, where this
activity was observed only in the second phase (3-4 h) of the
experiment. These results, therefore, suggest that the activity
of EEGP and the aqueous fraction may be related to the
inhibition of prostaglandin formation.
In relation to chemical analysis by HPLC, with
mobile phase optimized for polar compounds, two major
compounds could be identified, which shows the highly
polar characteristic of bioactive chemical compounds. No
flavonoid or phenolic acid was found in the aqueous fraction.
These phenolics are a class of chemicals reported in the
literature as responsible for most of the biological activity
of propolis from Apis mellifera [30, 31], thus suggesting a
different chemical profile of the geopropolis from Melipona
scutellaris, as evidenced in the aqueous fraction. Hence,
these chemical profile data suggest the presence of chemical
compounds that have not been reported in the literature
as to their pharmacological activities (especially anti-
inflammatory), which arouses special attention due to its
promising mechanism of action.
5. Conclusion
Therefore, we conclude that the EEGP and its aqueous frac-
tion decreased migration of neutrophils in the inflammatory
process, and this is dependent on the nitric oxide pathway.
Thus, due to their distinct chemical profile and promis-
ing mechanism of action, further studies are necessary for
the isolation and identification of bioactive compounds
present in the aqueous fraction, which may enable the
development of new effective anti-inflammatory drugs for the
treatment of inflammatory diseases.
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